Download PDF
Endoscopy 2007; 39(2): 101-105
DOI: 10.1055/s-2006-945108
Endoscopy essentials
© Georg Thieme Verlag KG Stuttgart · New York

Ulcer and gastritis

H.  Kashiwagi1
  • 1Department of Surgery, Jikei University School of Medicine, Tokyo, Japan
Further Information

Publication History

Publication Date:
27 February 2007 (online)

Also available at
    Permissions and Reprints

Five papers, discussing important topics related to ulcer and gastritis, have been selected for review here. The papers, which include some excellent systematic reviews and meta-analyses, were published between July 2005 and August 2006.

References

  • 1 Dixon M F, Genta R M, Yardley J H. et al . Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.  Am J Surg Pathol. 1996;  20 1161-1181
    CrossrefPubMedGoogle Scholar
  • 2 Naito Y, Ito M, Watanabe T. et al . Biomarkers in patients with gastric inflammation: a systematic review.  Digestion. 2005;  72 164-180
    CrossrefPubMedGoogle Scholar
  • 3 Ernst P B, Peura D A, Crowe S E. The translation of Helicobacter pylori basic research to patient care.  Gastroenterology. 2006;  130 188-206
    CrossrefPubMedGoogle Scholar
  • 4 Ouburg S, Bart A, Crusius J. et al . A candidate gene approach of immune mediators effecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections.  Eur J Gastroenterol Hepatol. 2005;  17 1213-1224
    CrossrefPubMedGoogle Scholar
  • 5 Tsai C J, Herrera-Goepfert R, Tibshirani R J. et al . Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy.  Cancer Epidemiol Biomarkers Prev. 2006;  15 272-280
    CrossrefPubMedGoogle Scholar
  • 6 Lu B, Chen M T, Fan Y H. et al . Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.  World J Gastroenterol. 2005;  11 6518-6520
    PubMedGoogle Scholar
  • 7 Mera R, Fontham E T, Bravo L E. et al . Long term follow up of patients treated for Helicobacter pylori infection.  Gut. 2005;  54 1536-1540
    CrossrefPubMedGoogle Scholar
  • 8 You W C, Brown L M, Zhang L. et al . Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.  J Natl Cancer Inst. 2006;  98 974-983
    CrossrefPubMedGoogle Scholar
  • 9 You W C, Zhang L, Grail M H. et al . Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.  J Natl Cancer Inst. 2000;  92 1607-1612
    CrossrefPubMedGoogle Scholar
  • 10 Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.  BMJ. 2005;  331 1310-1316
    CrossrefPubMedGoogle Scholar
  • 11 Scheiman J M, Yeomans N D, Talley N J. et al . Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.  Am J Gastroenterol. 2006;  101 701-710
    CrossrefPubMedGoogle Scholar
  • 12 Huang J-Q, Sridhar S, Hunt R H. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.  Lancet. 2002;  359 13-22
    PubMedGoogle Scholar
  • 13 Papatheodoridis G V, Sougioultzis S, Archimandritis A J. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.  Clin Gastroenterol Hepatol. 2006;  4 130-142
    CrossrefPubMedGoogle Scholar
  • 14 Lin H J, Lo W C, Cheng Y C. et al . Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.  Am J Gastroenterol. 2006;  101 500-505
    CrossrefPubMedGoogle Scholar
  • 15 Andrews C N, Levy A, Fishman M. et al . Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.  Can J Gastroenterol. 2005;  19 667-671
    PubMedGoogle Scholar
  • 16 Cook D J, Guyatt G H, Salena B J. et al . Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.  Gastroenterolgy. 1992;  102 139-148
    CrossrefPubMedGoogle Scholar
  • 17 Consensus conference: therapeutic endoscopy and rebleeding ulcers (review).  JAMA. 1989;  262 1369-1372
    CrossrefPubMedGoogle Scholar
  • 18 Kahi C J, Jensen D M, Sung J J. et al . Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis.  Gastroenterology. 2005;  129 855-862
    CrossrefPubMedGoogle Scholar
  • 19 Lau W Y, Leong K I, Kwong K H. et al . A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique.  Ann Surg. 1996;  224 131-138
    CrossrefPubMedGoogle Scholar
  • 20 Siu W T, Leong K I, Law B K. et al . Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial.  Ann Surg. 2002;  235 313-319
    CrossrefPubMedGoogle Scholar
  • 21 Lunevicius R, Morkevicius M. Systematic review comparing laparoscopic and open repair for perforated peptic ulcer.  Br J Surg. 2005;  92 1195-1207
    CrossrefPubMedGoogle Scholar
  • 22 Lunevicius R, Morkevicius M. Management strategies, early results, benefits, and risk factors of laparoscopic repair of perforated peptic ulcer.  World J Surg. 2005;  29 1299-1310
    CrossrefPubMedGoogle Scholar
  • 23 Boey J, Choi S K, Poon A. et al . Risk stratification in perforated duodenal ulcer: a prospective validation of predictive factors.  Ann Surg. 1987;  205 22-26
    PubMedGoogle Scholar

H. Kashiwagi, MD

Department of Surgery, Jikei University School of Medicine

3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461 Japan

Fax: + 81-3-5472-4140

Email: hkashiwagi.surg@jikei.ac.jp

      >